Jennison Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $105M | Buy |
|
|||||
2024
Q1 | $32.3M | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $23.1M | Buy |
|
|||||
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $1.09M | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $4.76M | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $37.4M | Sell |
|
|||||
2020
Q2 | $42.8M | Buy |
|
|||||
2020
Q1 | $22.7M | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $1.04M | Sell |
|
|||||
2019
Q1 | $1.4M | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $30.6M | Buy |
|
|||||
2017
Q4 | $28.5M | Sell |
|
|||||
2017
Q3 | $536M | Sell |
|
|||||
2017
Q2 | $635M | Buy |
|
|||||
2017
Q1 | $295M | Sell |
|
|||||
2016
Q4 | $704M | Sell |
|
|||||
2016
Q3 | $853M | Buy |
|
|||||
2016
Q2 | $709M | Sell |
|
|||||
2016
Q1 | $740M | Buy |
|
|||||
2015
Q4 | $1.09B | Buy |
|
|||||
2015
Q3 | $894M | Buy |
|
|||||
2015
Q2 | $884M | Buy |
|